Chargement en cours...
New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus
Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor. We report the case of a renal transplant recipient who developed d...
Enregistré dans:
| Publié dans: | An Bras Dermatol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Sociedade Brasileira de Dermatologia
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4540539/ https://ncbi.nlm.nih.gov/pubmed/26312705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20153672 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|